Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies.
SoRelle
Ruth
R
D000085:Acetates / Q000627:therapeutic use*; D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D000077542:Eptifibatide; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011379:Prognosis; D013577:Syndrome; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000085:Acetates; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; C084062:lamifiban; D000077542:Eptifibatide